Cargando…

Tumor suppressor gene alterations in patients with malignant mesothelioma due to environmental asbestos exposure in Turkey

BACKGROUND: Environmental asbestos exposure can cause the grave lung and pleura malignancies with a high mortality rate, and it is also associated with increased rate of other organ malignancies. Asbestos exposure can develop genotoxic effects and damage in the pleura and lungs. OBJECTIVE: In this s...

Descripción completa

Detalles Bibliográficos
Autores principales: Tug, Esra, Tug, Tuncer, Elyas, Halit, Coskunsel, Mehmet, Emri, Salih
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1559681/
https://www.ncbi.nlm.nih.gov/pubmed/16925806
http://dx.doi.org/10.1186/1477-3163-5-23
_version_ 1782129446262669312
author Tug, Esra
Tug, Tuncer
Elyas, Halit
Coskunsel, Mehmet
Emri, Salih
author_facet Tug, Esra
Tug, Tuncer
Elyas, Halit
Coskunsel, Mehmet
Emri, Salih
author_sort Tug, Esra
collection PubMed
description BACKGROUND: Environmental asbestos exposure can cause the grave lung and pleura malignancies with a high mortality rate, and it is also associated with increased rate of other organ malignancies. Asbestos exposure can develop genotoxic effects and damage in the pleura and lungs. OBJECTIVE: In this study, we aimed to determine tumor suppressor gene (TSG) loss in genomic DNA which was isolated from pleural fluid and blood samples of patients with Malignant Pleural Mesothelioma (MPM) due to environmental asbestos exposure. DESIGN AND PATIENTS: Prospective study of period from 2001 to 2003 in 17 patients with MPM. METHODS: A total of 12 chromosomal regions were researched by comparing genomic DNA samples isolated from blood and pleural effusion (using PCR, and polyacrilamid gel electrophoresis denaturizing), on 2 different chromosomes which have 9 different polymorphic determinants at 6q and 3 different polymorphic determinants at 9p using molecular genetic methods on 13 patients clinico-pathologically diagnosed MPM. RESULTS: Loss of Heterozygosity (LOH) was determined at D6S275 in one patient, at D6S301 in another, at D6S474 in 2, at ARG1 in 2, at D6S1038 in 2 and at D6S1008 in 3 patients. In 7 (54%) of the13 patients, we found LOH in at least one site. No LOH was determined at any informative loci in 6 patients. Of the 13 patients, no investigated markers were determined at 9p. CONCLUSION: In this study, genomic DNA samples obtained from MPM patients with asbestos exposure revealed that they contained important genotoxic damage. We found no other study on this subject at molecular level in pleural effusion either in Turkey or in the med-line literature. We believe that this study will provide important support for other research into molecular-genetic variations, both on this subject and other malignancies, and may also constitute a base for early diagnosis and gene therapy research in the future.
format Text
id pubmed-1559681
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-15596812006-09-05 Tumor suppressor gene alterations in patients with malignant mesothelioma due to environmental asbestos exposure in Turkey Tug, Esra Tug, Tuncer Elyas, Halit Coskunsel, Mehmet Emri, Salih J Carcinog Research BACKGROUND: Environmental asbestos exposure can cause the grave lung and pleura malignancies with a high mortality rate, and it is also associated with increased rate of other organ malignancies. Asbestos exposure can develop genotoxic effects and damage in the pleura and lungs. OBJECTIVE: In this study, we aimed to determine tumor suppressor gene (TSG) loss in genomic DNA which was isolated from pleural fluid and blood samples of patients with Malignant Pleural Mesothelioma (MPM) due to environmental asbestos exposure. DESIGN AND PATIENTS: Prospective study of period from 2001 to 2003 in 17 patients with MPM. METHODS: A total of 12 chromosomal regions were researched by comparing genomic DNA samples isolated from blood and pleural effusion (using PCR, and polyacrilamid gel electrophoresis denaturizing), on 2 different chromosomes which have 9 different polymorphic determinants at 6q and 3 different polymorphic determinants at 9p using molecular genetic methods on 13 patients clinico-pathologically diagnosed MPM. RESULTS: Loss of Heterozygosity (LOH) was determined at D6S275 in one patient, at D6S301 in another, at D6S474 in 2, at ARG1 in 2, at D6S1038 in 2 and at D6S1008 in 3 patients. In 7 (54%) of the13 patients, we found LOH in at least one site. No LOH was determined at any informative loci in 6 patients. Of the 13 patients, no investigated markers were determined at 9p. CONCLUSION: In this study, genomic DNA samples obtained from MPM patients with asbestos exposure revealed that they contained important genotoxic damage. We found no other study on this subject at molecular level in pleural effusion either in Turkey or in the med-line literature. We believe that this study will provide important support for other research into molecular-genetic variations, both on this subject and other malignancies, and may also constitute a base for early diagnosis and gene therapy research in the future. BioMed Central 2006-08-22 /pmc/articles/PMC1559681/ /pubmed/16925806 http://dx.doi.org/10.1186/1477-3163-5-23 Text en Copyright © 2006 Tug et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Tug, Esra
Tug, Tuncer
Elyas, Halit
Coskunsel, Mehmet
Emri, Salih
Tumor suppressor gene alterations in patients with malignant mesothelioma due to environmental asbestos exposure in Turkey
title Tumor suppressor gene alterations in patients with malignant mesothelioma due to environmental asbestos exposure in Turkey
title_full Tumor suppressor gene alterations in patients with malignant mesothelioma due to environmental asbestos exposure in Turkey
title_fullStr Tumor suppressor gene alterations in patients with malignant mesothelioma due to environmental asbestos exposure in Turkey
title_full_unstemmed Tumor suppressor gene alterations in patients with malignant mesothelioma due to environmental asbestos exposure in Turkey
title_short Tumor suppressor gene alterations in patients with malignant mesothelioma due to environmental asbestos exposure in Turkey
title_sort tumor suppressor gene alterations in patients with malignant mesothelioma due to environmental asbestos exposure in turkey
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1559681/
https://www.ncbi.nlm.nih.gov/pubmed/16925806
http://dx.doi.org/10.1186/1477-3163-5-23
work_keys_str_mv AT tugesra tumorsuppressorgenealterationsinpatientswithmalignantmesotheliomaduetoenvironmentalasbestosexposureinturkey
AT tugtuncer tumorsuppressorgenealterationsinpatientswithmalignantmesotheliomaduetoenvironmentalasbestosexposureinturkey
AT elyashalit tumorsuppressorgenealterationsinpatientswithmalignantmesotheliomaduetoenvironmentalasbestosexposureinturkey
AT coskunselmehmet tumorsuppressorgenealterationsinpatientswithmalignantmesotheliomaduetoenvironmentalasbestosexposureinturkey
AT emrisalih tumorsuppressorgenealterationsinpatientswithmalignantmesotheliomaduetoenvironmentalasbestosexposureinturkey